2Gurbel PA, Bliden KP, Guyer K, et al. Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study[J]. J Am Coll Cardiol, 2005, 46(10) : 1820 - 1826.
3Matetzky S, Shenkman B, Guetta V, et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patientswith acute myocardial infarction [ J ]. Circulation, 2004, 109 (25) :3171 -3175.
4Moussa I, Dimard C, remers B, et al. Subacute stent thrombosis in the era of interavascular ultrasound-guided coronary stenting without anticoagulation : frequency, predictors, and clinical outcome [ J ]. J Am Coll Cardiol, 1997, 29( 1 ) :6 - 12.
5Farb A, Burke AP, Kolodgie FD, et al. Pathological mechanisms of fatal late coronary stent thrombosis in humans [J]. Circulation, 2003, 108 (14) : 1701 - 1706.
6Mehta SR, Yusuf S, Peters ILl, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study [J]. Lancet, 2001,358(9281 ):527-533.
7Steinhubl SR, Berger PB, Mann JT 3rd, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention : a randomized controlled trial[ J ]. JAMA, 2002, 288 (19) : 2411 -2420.
8Cattaneo M. Aspirin and dopidogrel: Efficacy, safety, and the Issue of drug resistance J [ J ]. Arterioscler Thromb Vasc Biol, 2004, 24( 11 ) :1980 - 1987.
9Hobsen AR, Pefley GW, Dawkins KD, et al. A novel fifteen minute test for assessment of individual time-dependent clotting responses to aspirin and clopidogrel using modified thrombelastography [J]. Platelets, 2007, 18(7) :497 -505.
10Bliden KP, DiChiara J, Tantry US, et al. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing pereutaneous coronary intervention: is the current antiplatelet therapy adequate? [ J ]. J Am Coll Cardiol, 2007, 49 (6) : 657 - 666.
